Drug Approval | December 03, 2021
Biocon Pharma receives ANDA approval for Mycophenolic acid
This further adds to Biocon’s portfolio of vertically integrated complex drug products
This further adds to Biocon’s portfolio of vertically integrated complex drug products
The UK’s Medicine and Healthcare products Regulatory Agency has already approved the booster dose of AstraZenenca’s Covid-19 vaccine, which is administered in India
The U.S. FDA advisory committee voted 13-10 in favour of the oral antiviral medicine
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
Dabigatran Etexilate capsules are indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE)
The company is moving towards complex and more differentiated products
Nelarabine is in a class of medications called antimetabolites
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
The group now has 324 approvals and has so far filed over 400 ANDAs
The submission is based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11
Subscribe To Our Newsletter & Stay Updated
